17-1735723-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001163809.2(WDR81):​c.5325+6G>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00152 in 1,609,330 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0084 ( 15 hom., cov: 32)
Exomes 𝑓: 0.00080 ( 16 hom. )

Consequence

WDR81
NM_001163809.2 splice_region, intron

Scores

2
Splicing: ADA: 0.00008914
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.30

Publications

2 publications found
Variant links:
Genes affected
WDR81 (HGNC:26600): (WD repeat domain 81) This gene encodes a multi-domain transmembrane protein which is predominantly expressed in the brain and is thought to play a role in endolysosomal trafficking. Mutations in this gene are associated with an autosomal recessive form of a syndrome exhibiting cerebellar ataxia, cognitive disability, and disequilibrium (CAMRQ2). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
WDR81 Gene-Disease associations (from GenCC):
  • cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • cerebellar ataxia, intellectual disability, and dysequilibrium
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 17-1735723-G-C is Benign according to our data. Variant chr17-1735723-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 377010.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00839 (1277/152290) while in subpopulation AFR AF = 0.0285 (1186/41554). AF 95% confidence interval is 0.0272. There are 15 homozygotes in GnomAd4. There are 620 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WDR81NM_001163809.2 linkc.5325+6G>C splice_region_variant, intron_variant Intron 8 of 9 ENST00000409644.6 NP_001157281.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WDR81ENST00000409644.6 linkc.5325+6G>C splice_region_variant, intron_variant Intron 8 of 9 1 NM_001163809.2 ENSP00000386609.1

Frequencies

GnomAD3 genomes
AF:
0.00839
AC:
1276
AN:
152174
Hom.:
15
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0286
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00484
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00334
GnomAD2 exomes
AF:
0.00215
AC:
524
AN:
244254
AF XY:
0.00163
show subpopulations
Gnomad AFR exome
AF:
0.0289
Gnomad AMR exome
AF:
0.00143
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000547
Gnomad OTH exome
AF:
0.00101
GnomAD4 exome
AF:
0.000804
AC:
1171
AN:
1457040
Hom.:
16
Cov.:
31
AF XY:
0.000647
AC XY:
469
AN XY:
724704
show subpopulations
African (AFR)
AF:
0.0282
AC:
942
AN:
33356
American (AMR)
AF:
0.00191
AC:
84
AN:
44042
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25874
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39588
South Asian (SAS)
AF:
0.0000233
AC:
2
AN:
85952
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52228
Middle Eastern (MID)
AF:
0.00140
AC:
8
AN:
5730
European-Non Finnish (NFE)
AF:
0.0000288
AC:
32
AN:
1110074
Other (OTH)
AF:
0.00171
AC:
103
AN:
60196
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
63
126
190
253
316
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00839
AC:
1277
AN:
152290
Hom.:
15
Cov.:
32
AF XY:
0.00832
AC XY:
620
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0285
AC:
1186
AN:
41554
American (AMR)
AF:
0.00484
AC:
74
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68018
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
66
132
198
264
330
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000920
Hom.:
0
Bravo
AF:
0.00923
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 12, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
9.5
DANN
Benign
0.54
PhyloP100
1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000089
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115714169; hg19: chr17-1639017; API